Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Michel

Showing results (271-280 of 318) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|April 6, 2019
Autologous<sup>111</sup> Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonistsMatthieu Mahevas, Sandrine Van Eeckhoudt, Guillaume Moulis, et al.
British Journal of Haematology|April 27, 2017
Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort studyStéphane Ducassou, Guy Leverger, Helder Fernandes, et al.
Blood Advances|November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Donald M Arnold, James B Bussel, et al.
American Journal of Hematology|September 7, 2019
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-rituxSamuel Deshayes, Mehdi Khellaf, Anissa Zarour, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Blood|October 9, 2014
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patientsMehdi Khellaf, Anaïs Charles-Nelson, Olivier Fain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 RetrotransposonsMarc Michel, Maryam Heidary, Anissa Mechri, et al.
Medicine|August 29, 2013
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 CasesFanny Legrand, Aline Renneville, Elizabeth MacIntyre, et al.
Pageof 32

Showing results (271-280 of 318) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|April 6, 2019
Autologous<sup>111</sup> Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonistsMatthieu Mahevas, Sandrine Van Eeckhoudt, Guillaume Moulis, et al.
British Journal of Haematology|April 27, 2017
Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort studyStéphane Ducassou, Guy Leverger, Helder Fernandes, et al.
Blood Advances|November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Donald M Arnold, James B Bussel, et al.
American Journal of Hematology|September 7, 2019
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-rituxSamuel Deshayes, Mehdi Khellaf, Anissa Zarour, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Blood|October 9, 2014
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patientsMehdi Khellaf, Anaïs Charles-Nelson, Olivier Fain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 RetrotransposonsMarc Michel, Maryam Heidary, Anissa Mechri, et al.
Medicine|August 29, 2013
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 CasesFanny Legrand, Aline Renneville, Elizabeth MacIntyre, et al.
Pageof 32